Media professionals

  • Email
  • Help

Working with the media

This page highlights information which of specific interest to media professionals.

The page is kept updated with news, events and information for journalists with a professional interest in the development and availability of medicines in the European Union.

Featured information

News for media professionals

Events of interest

  • 10/12/2014


    Innovative Medicines Initiative WEB-RADR workshop

    The Innovative Medicines Initiative (IMI) WEB-RADR project aims to explore the use of mobile technologies and social media to further improve the collection and analysis of information on the suspected adverse drug reactions (ADRs). This includes the use of mobile apps to report adverse reactions, the possibility identifying potential safety issues with medicines from user comments (posts) on social media based on new visualisation technology and analytical methods as well as the safety information on medicines for patients, consumers and healthcare professionals. The workshop aims to identify stakeholder needs and expectations. Registration by invitation only. Places limited. ... Read more

  • 24/11/2014 - 25/11/2014


    European Medicines Agency workshop on the clinical investigation of medicines for the treatment of Alzheimer's disease

    The Agency is organising this workshop following the public-consultation exercise on its concept paper on the need for revision of the guideline on medicinal products for the treatment of Alzheimer’s disease and other dementias. The aim of the workshop is to make sure that, while revising its guideline, the EMA can take the most up-to-date scientific developments in understanding and treating Alzheimer’s disease into consideration, as well as the positions of experts in the field. Registration is open until 01/07/2014. Places limited. ... Read more

  • 01/12/2014


    Workshop on the 'Guideline on pharmaceutical development of medicines for paediatric use'

    The Quality Working Party is organising a workshop on the 'Guideline on pharmaceutical development of medicines for paediatric use'. The guideline has been in force as of February 2014 and is intended to provide additional guidance to pharmaceutical developers on quality aspects related to medicinal products for children between birth and 18 years of age. As more experience becomes available, further work is required to complement the guideline with additional recommendations on pharmaceutical development of paediatric medicines. The general scope of this workshop is to share the experience gained so far with the use of the guideline among stakeholders (regulators, healthcare professionals, academia and industry) and identify gaps in current knowledge. This workshop should be considered as a starting point for discussions. Registration closed. ... Read more

  • 04/12/2014 - 05/12/2014


    European Medicines Agency/European Federation of Pharmaceutical Industries and Associations workshop on the importance of dose finding and dose selection for the successful development, licensing and lifecycle management of medicinal products

    EMA/EFPIA workshop is planned for 4-5 December 2014 to discuss the importance of dose finding and dose selection for the successful development, licensing and lifecycle management of medicinal products. Registration: please register by 19 September 2014 using the registration form provided. ... Read more

  • 17/11/2014 - 21/11/2014


    European Commission - European Medicines Agency - China Food and Drugs Administration bilateral and International Summit of Heads of Medicines Regulatory Agencies

    The European Union China Working Group on Pharmaceuticals, which brings together the European Medicines Agency (EMA), the European Commission (EC) and the China Food and Drugs Administration, meets on 18 November to progress discussions on active-pharmaceutical-ingredient, good-clinical-practice and good-pharmacovigilance-practice inspection-related topics. The ninth International Summit of Heads of Medicines Regulatory Agencies takes place on 19-21 November, with representatives from EMA, EC, and a number of European, national and international partner regulators, including the World Health Organization. Discussions include registration of generics, biosimilars, access to medicines, innovative products and major public health concerns such as Ebola, antimicrobial resistance and dementia. The International Coalition of Medicines Regulatory Authorities meets on 20 November to review cooperation in good-manufacturing-practice inspection, information-sharing and capacity-building. ... Read more

  • See all Events of interest

Information for:

Find information for...

replacement banner for display on the home page upon the public release of the final version of the roadmap